Zylox-Tonbridge Medical Technology Co., Ltd.
Zylox-Tonbridge Medical Technology Co., Ltd. 2190.HK Peers
See (2190.HK) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 2190.HK | HK$18.66 | -1.06% | 5.8B | 56.55 | HK$0.33 | +0.58% |
| 2252.HK | HK$15.96 | -0.62% | 16.4B | -21.57 | -HK$0.74 | N/A |
| 0853.HK | HK$7.75 | -1.52% | 14.3B | -8.16 | -HK$0.95 | N/A |
| 2172.HK | HK$12.26 | -1.45% | 7.2B | 25.54 | HK$0.48 | +1.55% |
| 1302.HK | HK$1.53 | -3.16% | 6.7B | 25.50 | HK$0.06 | N/A |
| 1789.HK | HK$5.89 | -1.34% | 6.6B | 22.65 | HK$0.26 | +0.76% |
| 6606.HK | HK$14.14 | N/A | 6.3B | 58.92 | HK$0.24 | N/A |
| 1858.HK | HK$10.74 | -2.54% | 6.3B | 29.83 | HK$0.36 | +4.55% |
| 1763.HK | HK$14.86 | +13.41% | 4.7B | 10.77 | HK$1.38 | +7.23% |
| 9996.HK | HK$5.58 | -2.79% | 3.7B | -15.08 | -HK$0.37 | N/A |
Stock Comparison
2190.HK vs 2252.HK Comparison
2190.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2190.HK stands at 5.8B. In comparison, 2252.HK has a market cap of 16.4B. Regarding current trading prices, 2190.HK is priced at HK$18.66, while 2252.HK trades at HK$15.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2190.HK currently has a P/E ratio of 56.55, whereas 2252.HK's P/E ratio is -21.57. In terms of profitability, 2190.HK's ROE is +0.03%, compared to 2252.HK's ROE of -2.32%. Regarding short-term risk, 2190.HK is less volatile compared to 2252.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2190.HK.
2190.HK vs 0853.HK Comparison
2190.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2190.HK stands at 5.8B. In comparison, 0853.HK has a market cap of 14.3B. Regarding current trading prices, 2190.HK is priced at HK$18.66, while 0853.HK trades at HK$7.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2190.HK currently has a P/E ratio of 56.55, whereas 0853.HK's P/E ratio is -8.16. In terms of profitability, 2190.HK's ROE is +0.03%, compared to 0853.HK's ROE of -0.33%. Regarding short-term risk, 2190.HK is less volatile compared to 0853.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2190.HK.
2190.HK vs 2172.HK Comparison
2190.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2190.HK stands at 5.8B. In comparison, 2172.HK has a market cap of 7.2B. Regarding current trading prices, 2190.HK is priced at HK$18.66, while 2172.HK trades at HK$12.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2190.HK currently has a P/E ratio of 56.55, whereas 2172.HK's P/E ratio is 25.54. In terms of profitability, 2190.HK's ROE is +0.03%, compared to 2172.HK's ROE of +0.15%. Regarding short-term risk, 2190.HK is less volatile compared to 2172.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2190.HK.
2190.HK vs 1302.HK Comparison
2190.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2190.HK stands at 5.8B. In comparison, 1302.HK has a market cap of 6.7B. Regarding current trading prices, 2190.HK is priced at HK$18.66, while 1302.HK trades at HK$1.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2190.HK currently has a P/E ratio of 56.55, whereas 1302.HK's P/E ratio is 25.50. In terms of profitability, 2190.HK's ROE is +0.03%, compared to 1302.HK's ROE of +0.06%. Regarding short-term risk, 2190.HK is less volatile compared to 1302.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2190.HK.
2190.HK vs 1789.HK Comparison
2190.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2190.HK stands at 5.8B. In comparison, 1789.HK has a market cap of 6.6B. Regarding current trading prices, 2190.HK is priced at HK$18.66, while 1789.HK trades at HK$5.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2190.HK currently has a P/E ratio of 56.55, whereas 1789.HK's P/E ratio is 22.65. In terms of profitability, 2190.HK's ROE is +0.03%, compared to 1789.HK's ROE of +0.11%. Regarding short-term risk, 2190.HK is less volatile compared to 1789.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2190.HK.
2190.HK vs 6606.HK Comparison
2190.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2190.HK stands at 5.8B. In comparison, 6606.HK has a market cap of 6.3B. Regarding current trading prices, 2190.HK is priced at HK$18.66, while 6606.HK trades at HK$14.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2190.HK currently has a P/E ratio of 56.55, whereas 6606.HK's P/E ratio is 58.92. In terms of profitability, 2190.HK's ROE is +0.03%, compared to 6606.HK's ROE of -0.04%. Regarding short-term risk, 2190.HK is less volatile compared to 6606.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2190.HK.
2190.HK vs 1858.HK Comparison
2190.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2190.HK stands at 5.8B. In comparison, 1858.HK has a market cap of 6.3B. Regarding current trading prices, 2190.HK is priced at HK$18.66, while 1858.HK trades at HK$10.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2190.HK currently has a P/E ratio of 56.55, whereas 1858.HK's P/E ratio is 29.83. In terms of profitability, 2190.HK's ROE is +0.03%, compared to 1858.HK's ROE of +0.04%. Regarding short-term risk, 2190.HK is less volatile compared to 1858.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2190.HK.
2190.HK vs 1763.HK Comparison
2190.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2190.HK stands at 5.8B. In comparison, 1763.HK has a market cap of 4.7B. Regarding current trading prices, 2190.HK is priced at HK$18.66, while 1763.HK trades at HK$14.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2190.HK currently has a P/E ratio of 56.55, whereas 1763.HK's P/E ratio is 10.77. In terms of profitability, 2190.HK's ROE is +0.03%, compared to 1763.HK's ROE of +0.08%. Regarding short-term risk, 2190.HK is less volatile compared to 1763.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2190.HK.
2190.HK vs 9996.HK Comparison
2190.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2190.HK stands at 5.8B. In comparison, 9996.HK has a market cap of 3.7B. Regarding current trading prices, 2190.HK is priced at HK$18.66, while 9996.HK trades at HK$5.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2190.HK currently has a P/E ratio of 56.55, whereas 9996.HK's P/E ratio is -15.08. In terms of profitability, 2190.HK's ROE is +0.03%, compared to 9996.HK's ROE of -0.11%. Regarding short-term risk, 2190.HK is less volatile compared to 9996.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2190.HK.
2190.HK vs 2235.HK Comparison
2190.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2190.HK stands at 5.8B. In comparison, 2235.HK has a market cap of 2.6B. Regarding current trading prices, 2190.HK is priced at HK$18.66, while 2235.HK trades at HK$6.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2190.HK currently has a P/E ratio of 56.55, whereas 2235.HK's P/E ratio is -38.75. In terms of profitability, 2190.HK's ROE is +0.03%, compared to 2235.HK's ROE of -0.03%. Regarding short-term risk, 2190.HK is less volatile compared to 2235.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2190.HK.
2190.HK vs 2500.HK Comparison
2190.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2190.HK stands at 5.8B. In comparison, 2500.HK has a market cap of 2.5B. Regarding current trading prices, 2190.HK is priced at HK$18.66, while 2500.HK trades at HK$5.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2190.HK currently has a P/E ratio of 56.55, whereas 2500.HK's P/E ratio is -3.18. In terms of profitability, 2190.HK's ROE is +0.03%, compared to 2500.HK's ROE of -0.23%. Regarding short-term risk, 2190.HK is less volatile compared to 2500.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2190.HK.
2190.HK vs 6669.HK Comparison
2190.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2190.HK stands at 5.8B. In comparison, 6669.HK has a market cap of 2.3B. Regarding current trading prices, 2190.HK is priced at HK$18.66, while 6669.HK trades at HK$7.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2190.HK currently has a P/E ratio of 56.55, whereas 6669.HK's P/E ratio is 42.94. In terms of profitability, 2190.HK's ROE is +0.03%, compared to 6669.HK's ROE of +0.04%. Regarding short-term risk, 2190.HK is less volatile compared to 6669.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2190.HK.
2190.HK vs 1696.HK Comparison
2190.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2190.HK stands at 5.8B. In comparison, 1696.HK has a market cap of 2.3B. Regarding current trading prices, 2190.HK is priced at HK$18.66, while 1696.HK trades at HK$4.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2190.HK currently has a P/E ratio of 56.55, whereas 1696.HK's P/E ratio is 11.62. In terms of profitability, 2190.HK's ROE is +0.03%, compared to 1696.HK's ROE of +0.05%. Regarding short-term risk, 2190.HK is less volatile compared to 1696.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2190.HK.
2190.HK vs 2160.HK Comparison
2190.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2190.HK stands at 5.8B. In comparison, 2160.HK has a market cap of 2.1B. Regarding current trading prices, 2190.HK is priced at HK$18.66, while 2160.HK trades at HK$0.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2190.HK currently has a P/E ratio of 56.55, whereas 2160.HK's P/E ratio is -44.00. In terms of profitability, 2190.HK's ROE is +0.03%, compared to 2160.HK's ROE of -0.02%. Regarding short-term risk, 2190.HK is less volatile compared to 2160.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2190.HK.
2190.HK vs 2216.HK Comparison
2190.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2190.HK stands at 5.8B. In comparison, 2216.HK has a market cap of 1.2B. Regarding current trading prices, 2190.HK is priced at HK$18.66, while 2216.HK trades at HK$2.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2190.HK currently has a P/E ratio of 56.55, whereas 2216.HK's P/E ratio is -8.83. In terms of profitability, 2190.HK's ROE is +0.03%, compared to 2216.HK's ROE of -0.09%. Regarding short-term risk, 2190.HK is less volatile compared to 2216.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2190.HK.
2190.HK vs 6609.HK Comparison
2190.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2190.HK stands at 5.8B. In comparison, 6609.HK has a market cap of 1.1B. Regarding current trading prices, 2190.HK is priced at HK$18.66, while 6609.HK trades at HK$27.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2190.HK currently has a P/E ratio of 56.55, whereas 6609.HK's P/E ratio is -70.51. In terms of profitability, 2190.HK's ROE is +0.03%, compared to 6609.HK's ROE of -0.01%. Regarding short-term risk, 2190.HK is less volatile compared to 6609.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2190.HK.
2190.HK vs 2170.HK Comparison
2190.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2190.HK stands at 5.8B. In comparison, 2170.HK has a market cap of 752.2M. Regarding current trading prices, 2190.HK is priced at HK$18.66, while 2170.HK trades at HK$2.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2190.HK currently has a P/E ratio of 56.55, whereas 2170.HK's P/E ratio is -2.93. In terms of profitability, 2190.HK's ROE is +0.03%, compared to 2170.HK's ROE of -0.20%. Regarding short-term risk, 2190.HK is less volatile compared to 2170.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2190.HK.
2190.HK vs 6118.HK Comparison
2190.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2190.HK stands at 5.8B. In comparison, 6118.HK has a market cap of 348.6M. Regarding current trading prices, 2190.HK is priced at HK$18.66, while 6118.HK trades at HK$0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2190.HK currently has a P/E ratio of 56.55, whereas 6118.HK's P/E ratio is 22.67. In terms of profitability, 2190.HK's ROE is +0.03%, compared to 6118.HK's ROE of +0.02%. Regarding short-term risk, 2190.HK is less volatile compared to 6118.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2190.HK.
2190.HK vs 1612.HK Comparison
2190.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2190.HK stands at 5.8B. In comparison, 1612.HK has a market cap of 254.1M. Regarding current trading prices, 2190.HK is priced at HK$18.66, while 1612.HK trades at HK$0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2190.HK currently has a P/E ratio of 56.55, whereas 1612.HK's P/E ratio is 3.59. In terms of profitability, 2190.HK's ROE is +0.03%, compared to 1612.HK's ROE of +0.12%. Regarding short-term risk, 2190.HK is more volatile compared to 1612.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2190.HK.
2190.HK vs 2297.HK Comparison
2190.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2190.HK stands at 5.8B. In comparison, 2297.HK has a market cap of 245.2M. Regarding current trading prices, 2190.HK is priced at HK$18.66, while 2297.HK trades at HK$0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2190.HK currently has a P/E ratio of 56.55, whereas 2297.HK's P/E ratio is -1.91. In terms of profitability, 2190.HK's ROE is +0.03%, compared to 2297.HK's ROE of -0.26%. Regarding short-term risk, 2190.HK is less volatile compared to 2297.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2190.HK.
2190.HK vs 2393.HK Comparison
2190.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2190.HK stands at 5.8B. In comparison, 2393.HK has a market cap of 214.5M. Regarding current trading prices, 2190.HK is priced at HK$18.66, while 2393.HK trades at HK$0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2190.HK currently has a P/E ratio of 56.55, whereas 2393.HK's P/E ratio is 0.21. In terms of profitability, 2190.HK's ROE is +0.03%, compared to 2393.HK's ROE of +1.71%. Regarding short-term risk, 2190.HK is less volatile compared to 2393.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2190.HK.